Tag: #biotech

Neurocrine to Buy Soleno for $2.9 Billion, Picks Up Prader‑Willi Drug VYKAT XR

Neurocrine will acquire Soleno for $2.9B to add VYKAT XR, the newly approved Prader‑Willi hyperphagia drug, aiming to expand its rare‑disease portfolio.

#biotech, #m&a, #raredisease

Oramed Sells Oral-Insulin Unit to Lifeward, Takes Major Stake in Exoskeleton Maker

Oramed sells its oral drug unit to Lifeward, receiving shares, warrants, royalties and convertible notes—positioning it as a near-control shareholder.

#biotech, #medtech, #nasdaq, #exoskeleton, #convertiblenotes

Open-Source ‘DNA GPT’ Evo 2 Hits the Internet, Raising Hopes for Medicine—and New Biosecurity Questions

A new 40B-parameter genome AI, Evo 2, is released with open weights and data—boosting research while testing safeguards against biological misuse.

#ai, #genomics, #biosecurity, #openai, #biotech